Long-term activation of mast cells as an experimental model for studying their role in the regulation of spermatogenesis
- 作者: Sadek A.1,2, Pechenkina M.A.1, Khramtsova Y.S.3
-
隶属关系:
- B. Yeltsin Ural Federal University
- Institute of Medical Cell Technologies
- Institute of Immunology and Physiology of the Ural Branch of the Russian Academy of Sciences
- 期: 卷 28, 编号 3 (2025)
- 页面: 487-494
- 栏目: SHORT COMMUNICATIONS
- URL: https://journal-vniispk.ru/1028-7221/article/view/319890
- DOI: https://doi.org/10.46235/1028-7221-17180-LTA
- ID: 319890
如何引用文章
全文:
详细
Mast cells are an important component of the immune microenvironment in the male reproductive system, involved in both physiological regulation and pathological processes via secretion of various bioactive substances. Modeling dysregulation through activation or inhibition of mast cells, and studying the impact of this disturbance on spermatogenesis, may help identify the precise regulatory mechanisms by which these cells influence this process. Ciprofloxacin, an antibiotic known to activate mast cells, has shown efficiency in cardiac mast cell studies but has not been investigated in spermatogenesis. The aim of this study was to evaluate the effects of various ciprofloxacin regimens on mast cells in reproductive organs of male Wistar rats and to determine an optimal dose and duration for developing a model suitable for investigating mast cell involvement in spermatogenesis. Male Wistar rats were treated with ciprofloxacin at 200 and 400 mg/kg for different durations. Morphological and functional characteristics of mast cells in the testes and epididymides were assessed histologically. Ciprofloxacin was shown to modulate the mast cell activity in a time-, dose-, and tissue- dependent manner. At a dose of 200 mg/kg for 7 days, it caused an increase in mast cell numbers, enhanced synthetic activity, and raised the proportion of cells with mature granules in both organs, while degranulation remained unchanged. This indicates a “preparatory” phase involving mast cell migration to reproductive tissues and granule accumulation. This process was followed by active degranulation after 14 days, associated with return to baseline cell numbers, sustained high synthetic activity, and a predominance of mast cells with mature granules, especially in testes. A higher сiprofloxacin dose (400 mg/kg) promoted acceleration of mast cell activation, leading to earlier degranulation. While functional changes were consistent across both organs, morphometric parameters and granule maturation showed tissue-specific responses. Notably, testicular mast cells displayed minimal morphometric changes, possibly due to the immune-privileged nature of the testes. Based on these findings, a 400 mg/kg dose for 7 days is recommended to induce mast cell activation for spermatogenesis studies. A 200 mg/kg сiprofloxacin dose is more suitable for pre-stimulation prior to the use of a degranulation inducer and for long-term studies, in order to minimize possible side effects associated with higher doses.
作者简介
A. Sadek
B. Yeltsin Ural Federal University; Institute of Medical Cell Technologies
Email: sadek1996@mail.ru
Postgraduate Student, Research Engineer at the Department of Biology and Fundamental Medicine; Researcher at the Central Experimental Laboratory of Biotechnologies
俄罗斯联邦, Ekaterinburg; EkaterinburgM. Pechenkina
B. Yeltsin Ural Federal University
Email: sadek1996@mail.ru
Student at the Department of Biology and Fundamental Medicine
俄罗斯联邦, EkaterinburgYu. Khramtsova
Institute of Immunology and Physiology of the Ural Branch of the Russian Academy of Sciences
编辑信件的主要联系方式.
Email: sadek1996@mail.ru
PhD (Biology), Associate Professor, Senior Researcher at the Laboratory of Immunophysiology and Immunopharmacology
俄罗斯联邦, Ekaterinburg参考
- Bankhead P., Loughrey M.B., Fernández J.A., Dombrowski Y., McArt D.G., Dunne P.D., McQuaid S., Gray R.T., Murray L.J., Coleman H.G. QuPath: Open source software for digital pathology image analysis. Sci. Rep., 2017, Vol. 7, no. 1, 16878. doi: 10.1038/s41598-017-17204-5
- Baran J., Sobiepanek A., Mazurkiewicz-Pisarek A., Rogalska M., Gryciuk A., Kuryk L., Abraham S.N., Staniszewska M. Mast cells as a target – A comprehensive review of recent therapeutic approaches. Cells, 2023, Vol. 12, no. 8, 1187. doi: 10.3390/cells12081187.
- Himelreich-Perić M., Katušić-Bojanac A., Hohšteter M., Sinčić N., Mužić-Radović V., Ježek D. Mast cells in the mammalian testis and epididymis – Animal models and detection methods. Int. J. Mol. Sci., 2022, Vol. 23, no. 5, 2547. doi: 10.3390/ijms23052547.
- Kuzmin V., Voronina Y., Abramov A., Karkhov A., Fedorov A. Prolonged stimulation of resident mast cells suppresses the automaticity of the sinus node of the heart via histamine H1 receptors. Receptors and Intracellular Signaling, 2023, pp. 404-408. (In Russ.)
- Liu R., Hu S., Zhang Y., Che D., Cao J., Wang J., Zhao T., Jia Q., Wang N., Zhang T. Mast cell-mediated hypersensitivity to fluoroquinolone is MRGPRX2 dependent. Int. Immunopharmacol., 2019, Vol. 70, pp. 417-427.
- McNeil B.D. MRGPRX2 and adverse drug reactions. Front. Immunol., 2021, Vol. 12, 676354. doi: 10.3389/fimmu.2021.676354.
- McNeil B.D., Pundir P., Meeker S., Han L., Undem B.J., Kulka M., Dong X. Identification of a mast-cell-specific receptor crucial for pseudo-allergic drug reactions. Nature, 2015, Vol. 519, no. 7542, pp. 237-241.
- Sadek A., Khramtsova Y., Yushkov B. Mast cells as a component of spermatogonial stem cells’ microenvironment. Int. J. Mol. Sci., 2024, Vol. 25, no. 23, 13177. doi: 10.3390/ijms252313177.
- Schindelin J., Arganda-Carreras I., Frise E., Kaynig V., Longair M., Pietzsch T., Preibisch S., Rueden C., Saalfeld S., Schmid B. Fiji: an open-source platform for biological-image analysis. Nat. Methods, 2012, Vol. 9, no. 7, pp. 676-682.
补充文件
